Johnson & Johnson (JNJ) engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments viz., (1) Consumer; (2) Pharmaceutical; and (3) Medical Devices and Diagnostics. The company was founded in 1886 and is based in New Brunswick, New Jersey.
JNJ is a part of the dividend aristocrats, S&P500 index, and DJIA index. It has been raising its dividend for last 48 years. The latest increase in dividend was 9.3% in May 2010. My objective here is to analyze JNJ to determine fair price range for buying and adding to existing positions.
Trend Analysis
Here I am looking at trends for past 10 years of corporation’s revenue and profitability. These parameters should show consistently growth trends. The trend charts are shown in image below. continue reading rest of the article….
This article was originally published on 



~
What is your preference – Aristocrats or Achievers?
In general, for any dividend growth investor, the list of dividend aristocrats is favorite hunting ground. This list includes companies from S&P500 index that have been raising dividends consecutively for last 25 years. These are mature companies that have time and again shown they can perform in all economic cycles. Their management’s have consistently shown that they care about common shareholders dividends and believe in increasing at least to little more than inflation.
continue reading rest of the article….